Mentice AB (MNTC) - Net Assets
Based on the latest financial reports, Mentice AB (MNTC) has net assets worth Skr123.36 Million SEK (≈ $13.28 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr299.56 Million ≈ $32.24 Million USD) and total liabilities (Skr176.20 Million ≈ $18.96 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MNTC tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr123.36 Million |
| % of Total Assets | 41.18% |
| Annual Growth Rate | 13.96% |
| 5-Year Change | 1.09% |
| 10-Year Change | N/A |
| Growth Volatility | 31.81 |
Mentice AB - Net Assets Trend (2017–2025)
This chart illustrates how Mentice AB's net assets have evolved over time, based on quarterly financial data. See MNTC defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Mentice AB (2017–2025)
The table below shows the annual net assets of Mentice AB from 2017 to 2025. For live valuation and market cap data, see MNTC company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr138.38 Million ≈ $14.89 Million |
-3.68% |
| 2024-12-31 | Skr143.66 Million ≈ $15.46 Million |
-9.63% |
| 2023-12-31 | Skr158.97 Million ≈ $17.11 Million |
-2.25% |
| 2022-12-31 | Skr162.63 Million ≈ $17.50 Million |
+18.81% |
| 2021-12-31 | Skr136.89 Million ≈ $14.73 Million |
-16.15% |
| 2020-12-31 | Skr163.25 Million ≈ $17.57 Million |
+30.85% |
| 2019-12-31 | Skr124.77 Million ≈ $13.43 Million |
+86.94% |
| 2018-12-31 | Skr66.74 Million ≈ $7.18 Million |
+37.21% |
| 2017-12-31 | Skr48.64 Million ≈ $5.23 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Mentice AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 368.6% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr1.41 Million | 1.02% |
| Other Components | Skr232.98 Million | 168.37% |
| Total Equity | Skr138.38 Million | 100.00% |
Mentice AB Competitors by Market Cap
The table below lists competitors of Mentice AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NXT Energy Solutions Inc
TO:SFD
|
$38.90 Million |
|
SKY LIGHT HOLDINGS LTD
F:27L
|
$38.91 Million |
|
M.J. International Co Ltd
TW:8466
|
$38.92 Million |
|
ACELRX PHARMACEUT. DL-01
F:R5XA
|
$38.92 Million |
|
Gossamer Bio Inc
NASDAQ:GOSS
|
$38.88 Million |
|
Heerim Architects & Planners Co. Ltd
KQ:037440
|
$38.88 Million |
|
Microequities Asset Management Group Ltd
AU:MAM
|
$38.88 Million |
|
Korea Refract
KO:010040
|
$38.86 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mentice AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 143,663,000 to 138,376,000, a change of -5,287,000 (-3.7%).
- Net loss of 32,334,000 reduced equity.
- New share issuances of 31,961,000 increased equity.
- Other comprehensive income decreased equity by 664,000.
- Other factors decreased equity by 4,250,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-32.33 Million | -23.37% |
| Share Issuances | Skr31.96 Million | +23.1% |
| Other Comprehensive Income | Skr-664.00K | -0.48% |
| Other Changes | Skr-4.25 Million | -3.07% |
| Total Change | Skr- | -3.68% |
Book Value vs Market Value Analysis
This analysis compares Mentice AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.61x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 6.38x to 2.61x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | Skr2.01 | Skr12.85 | x |
| 2018-12-31 | Skr2.76 | Skr12.85 | x |
| 2019-12-31 | Skr6.38 | Skr12.85 | x |
| 2020-12-31 | Skr6.72 | Skr12.85 | x |
| 2021-12-31 | Skr5.53 | Skr12.85 | x |
| 2022-12-31 | Skr6.45 | Skr12.85 | x |
| 2023-12-31 | Skr6.22 | Skr12.85 | x |
| 2024-12-31 | Skr5.62 | Skr12.85 | x |
| 2025-12-31 | Skr4.92 | Skr12.85 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mentice AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -23.37%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -11.59%
- • Asset Turnover: 0.89x
- • Equity Multiplier: 2.25x
- Recent ROE (-23.37%) is below the historical average (-6.64%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 12.71% | 5.67% | 1.16x | 1.93x | Skr1.32 Million |
| 2018 | 30.19% | 12.83% | 1.20x | 1.96x | Skr13.47 Million |
| 2019 | -16.51% | -13.79% | 0.80x | 1.50x | Skr-33.08 Million |
| 2020 | -8.02% | -9.52% | 0.56x | 1.50x | Skr-29.42 Million |
| 2021 | -21.32% | -15.77% | 0.71x | 1.91x | Skr-42.88 Million |
| 2022 | -18.86% | -14.07% | 0.65x | 2.05x | Skr-46.93 Million |
| 2023 | -1.77% | -1.03% | 0.85x | 2.03x | Skr-18.71 Million |
| 2024 | -12.82% | -6.34% | 0.90x | 2.25x | Skr-32.79 Million |
| 2025 | -23.37% | -11.59% | 0.89x | 2.25x | Skr-46.17 Million |
Industry Comparison
This section compares Mentice AB's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $154,871,216
- Average return on equity (ROE) among peers: -59.99%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mentice AB (MNTC) | Skr123.36 Million | 12.71% | 1.43x | $38.89 Million |
| Acarix A/S (ACARIX) | $100.54 Million | -51.52% | 0.18x | $31.21 Million |
| Arcoma AB (ARCOMA) | $49.53 Million | 2.76% | 0.92x | $13.61 Million |
| Bactiguard Holding AB (publ) (BACTI-B) | $387.11 Million | -0.84% | 0.62x | $54.96 Million |
| BICO Group AB (BICO) | $549.64 Million | 0.11% | 0.10x | $124.14 Million |
| Boule Diagnostics AB (BOUL) | $192.86 Million | 6.07% | 0.41x | $13.37 Million |
| CellaVision AB (CEVI) | $206.18 Million | 29.00% | 0.24x | $351.14 Million |
| Clinical Laserthermia Systems AB (publ) (CLS-B) | $3.68 Million | -18.24% | 0.50x | $11.99 Million |
| Chordate Medical Holding AB (CMH) | $15.09 Million | -193.46% | 0.46x | $29.05K |
| C-Rad AB (publ) (CRAD-B) | $38.03 Million | -55.21% | 0.62x | $127.56 Million |
| Duearity AB (DEAR) | $6.06 Million | -318.56% | 0.99x | $331.97K |
About Mentice AB
Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedura… Read more